Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms

Inclusion Criteria: * Body Mass Index (BMI) of 20 to 35 kg/m2. * Visible excess of adipose tissue at the treatment site * Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring and/or weight loss during study participation. * No procedure for fat reduction in the area in the last six months. * Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting a significant change of weight in either direction during the study participation. Exclusion Criteria: * Electronic implants (such as cardiac pacemakers, defibrillators, and neurostimulators) * Cardiovascular diseases * Vascular diseases (such as chronic venous insufficiency, deep venous thrombosis, varicose veins, etc.) * Disturbance of temperature or pain perception * Pulmonary insufficiency * Metal implants * Drug pumps * Malignant tumor * Hemorrhagic conditions * Septic conditions and empyema * Acute inflammations * Systemic or local infection such as osteomyelitis and tuberculosis * Contagious skin disease * Elevated body temperature * Pregnancy * Breastfeeding * Injured or otherwise impaired muscles in the arms * Scars, open lesions, and wounds at the treatment area * Basedow's disease * Previous liposuction in the treatment area in the last six months * Any other disease or condition at the investigator's discretion, e.g. dislocated shoulder or carpal tunnel syndrome than can pose danger to th…